Citadel Advisors
AMRI

Citadel Advisors’s Albany Molecular Research Inc AMRI Stock Holding History

Citadel Advisors’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-137,557
Closed -$1.93M – 8502
2017
Q1 		$1.93M Buy
137,557
+100,513
+271% +$1.65M ﹤0.01% 3119
2016
Q4 		$695K Buy
+37,044
New +$630K ﹤0.01% 4392
2016
Q3 		– Sell
-79,516
Closed -$1.07M – 8136
2016
Q2 		$1.07M Buy
79,516
+56,182
+241% +$820K ﹤0.01% 3469
2016
Q1 		$357K Sell
23,334
-10,317
-31% -$162K ﹤0.01% 4867
2015
Q4 		$668K Buy
33,651
+17,097
+103% +$325K ﹤0.01% 4096
2015
Q3 		$288K Buy
16,554
+7,048
+74% +$144K ﹤0.01% 5630
2015
Q2 		$192K Buy
9,506
+5,676
+148% +$110K ﹤0.01% 6381
2015
Q1 		$67K Buy
3,830
+3,044
+387% +$51.9K ﹤0.01% 7180
2014
Q4 		$13K Sell
786
-7,586
-91% -$139K ﹤0.01% 8054
2014
Q3 		$185K Sell
8,372
-11
-0.1% -$225 ﹤0.01% 5803
2014
Q2 		$169K Sell
8,383
-6,818
-45% -$115K ﹤0.01% 5745
2014
Q1 		$283K Sell
15,201
-12,105
-44% -$167K ﹤0.01% 5089
2013
Q4 		$275K Sell
27,306
-29,251
-52% -$353K ﹤0.01% 4691
2013
Q3 		$729K Sell
56,557
-122,861
-68% -$1.51M ﹤0.01% 3417
2013
Q2 		$2.13M Buy
+179,418
New +$1.94M ﹤0.01% 2431

Other funds holding AMRI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Citadel Advisors's AMRI Position: Q2 2017 in Review

Citadel Advisors sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 137,557 shares — an estimated $1.93M sold.

Citadel Advisors first reported a position in AMRI in Q2 2013 and held it in 15 quarters. The position peaked at $2.13M in Q2 2013. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

  • Citadel Advisors reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
  • Citadel Advisors sold 137,557 Albany Molecular Research Inc shares in Q2 2017, an estimated $1.93M.
  • Citadel Advisors first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 15 quarters.
  • Citadel Advisors's Albany Molecular Research Inc position peaked at $2.13M in Q2 2013.
  • 136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.